Pubblicazioni

Autori:

Longo, Chiara; Geraci, Luca; Tomaiuolo, Luisa; Autelitano, Daniele; Todesco, Marco; Rossi, Vittoria; Cicalò, Francesco; Verrengia, Francesco; D'Onofrio, Mirko

Titolo:

Radiogenomics of Pancreatic Ductal AdenoCarcinoma

Anno:

2022

Tipologia prodotto:

Poster

Tipologia ANVUR:

Poster

Lingua:

Inglese

Formato:

Elettronico

Titolo del Convegno:

ECR 2022 - ESR - European Society of Radiology

Luogo:

Austria Center Vienna, Austria

Periodo:

13/07/2022 – 17/07/2022

Intervallo pagine:

1-1

Parole chiave:

Artificial Intelligence, Oncology, Pancreas, CT, MR, Experimental investigations, Outcomes analysis, Radiobiology, Tissue characterisation

Breve descrizione dei contenuti:

The aim of our study was to perform a simplified radiomic analysis of pancreatic ductal adenocarcinoma based on qualitative and quantitative tumor features and to compare the results with different muted genes, in particular with KRAS and TP53 expression, in order to predict the outcome and, in future, to direct the therapeutic path.

Note:

Pancreatic cancer has a very poor prognosis and its most frequent isotype is represented by pancreatic ductal adenocarcinoma (PDAC). Despite advances in early diagnosis and multimodal treatments, the prognosis for patients with PDAC remains poor, with a 5-year survival rate that lies around 8%. According to genomics, there are certain genes often mutated in PDAC’s carcinogenesis: KRAS, CDKN2a/INK4a, TP53, and DPC4/SMAD4. In particular we focused on the presence or absence of KRAS mutation as it is the most frequent mutated oncogene (95%) that determine an increased growth and survival of tumoral cells. Secondly we analyzed TP53 expression as it is demonstrated that it is inactivated in up to 75% of the PDAC. The aim of our study was to perform a simplified radiomic analysis of pancreatic ductal adenocarcinoma based on qualitative and quantitative tumor features and to compare the results with different muted genes, in particular with KRAS and TP53 expression, in order to predict the outcome and, in future, to direct the therapeutic path. At our knowledge, this is the first study that looks for radiogenomic data for PDAC through RM imaging.

Pagina Web:

https://dx.doi.org/10.26044/ecr2022/C-14768

Id prodotto:

132157

Handle IRIS:

11562/1075328

ultima modifica:

23 febbraio 2023

Citazione bibliografica:

Longo, Chiara; Geraci, Luca; Tomaiuolo, Luisa; Autelitano, Daniele; Todesco, Marco; Rossi, Vittoria; Cicalò, Francesco; Verrengia, Francesco; D'Onofrio, Mirko, Radiogenomics of Pancreatic Ductal AdenoCarcinoma  in EPOS , Atti di "ECR 2022 - ESR - European Society of Radiology" , Austria Center Vienna, Austria , 13/07/2022 – 17/07/2022 , 2022 , pp. 1-1

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo